For assignments, theAccepted Formatis as follow:11pts“Times New Roman”,Doublespaced fonts must be used as well as the standard margins in Word. Please the professor said that the rate of similarity is...

Analytical Report on Neuralink: An Innovative Company that is Revolutionizing the Future of Brain-Machine Interfaces
Analytical Report on Neuralink: An Innovative Company that is Revolutionizing the Future of Brain-Machine Interfaces
Assignment
Introduction
Neuralink was founded in 2016 by Elon Musk, who is known for his work with Tesla, SpaceX, and other innovative companies. The company's mission is to develop BMI technology to improve human communication with technology and help people with neurological conditions such as paralysis, Alzheimer’s disease, and other
ain-related disorders (Stiles, 2021).
The company's innovative approach is based on developing implantable devices that can interface directly with the
ain, providing a more efficient and precise connection between the
ain and technology. The implantable device consists of flexible threads with multiple electrodes that are placed in the
ain through a small hole in the skull. These electrodes can detect neural activity with high precision, enabling direct communication between the
ain and technology. Neuralink's approach is different from traditional BMI technology, which typically relies on external devices that capture signals from the
ain and translate them into actions (Stiles, 2021). Neuralink's implantable technology has the potential to revolutionize how we interact with technology and could help people with disabilities to regain their ability to communicate and perform everyday tasks.
In terms of growth, Neuralink has come a long way since its inception in 2016. The company has received substantial investments from prominent investors, including Elon Musk himself, and has also received significant attention from the media and the public, which has helped to raise awareness about the potential of BMI technology. One of the key milestones in Neuralink's growth was the announcement of its first working prototype in 2019. The prototype demonstrated the ability to read and write information to the
ain of a pig, showing the potential of the technology and its ability to
idge the gap between the
ain and technology ("Brain-computer interface," 2022).
Another significant milestone for Neuralink was the announcement of its first human trials in 2020. The company received approval from the U.S. Food and Drug Administration to conduct clinical trials on humans with neurological conditions such as paralysis. The trials are ongoing, and the results could provide important insights into the potential of the technology and its ability to improve the lives of people with disabilities ("Brain-computer interface," 2022).
In 2021, Neuralink made another significant announcement, revealing that it had developed a wireless version of its implantable BMI technology. The wireless version eliminates the need for a physical connection between the implant and external devices, making it more convenient and accessible for users.
Innovation
Neuralink's innovation lies in its ability to develop implantable BMI technology that provides a more direct and efficient connection between the
ain and technology. The company's approach is different from traditional BMI technology that relies on external devices to capture signals from the
ain and translate them into actions. Essentially, Neuralink is a neurotechnology company that is focused on developing innovative implantable
ain-machine interfaces to improve human communication with technology. The company's approach is different from traditional BMI technology, and its implantable devices have the...